Funding Opportunities

• Mechanisms of Alcohol-associated Cancers (R21)
  (PA-17-219)
  National Institute on Alcohol Abuse and Alcoholism
  National Cancer Institute
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Mechanisms of Alcohol-associated Cancers (R01)
  (PA-17-220)
  National Institute on Alcohol Abuse and Alcoholism
  National Cancer Institute
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Supplements for Validating the Use of Automated Sources of Residential Histories in Cancer Epidemiology Cohorts (Admin Supp)
  (PA-17-222)
  National Cancer Institute
  Application Receipt Date(s): June 1, 2017, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Supplement Opportunity to Support Population-Based Research Studies of Rare Cancers (Admin Supp)
  (PA-17-223)
  National Cancer Institute
  Application Receipt Date(s): June 1, 2017, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Research Supplements to Promote Sharing Data in Cancer Epidemiology Studies (Admin Supp)
  (PA-17-224)
  National Cancer Institute
  Application Receipt Date(s): June 1, 2017, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Enhancing Science, Technology, EnginEering, and Math Educational Diversity (ESTEEMED) Research Education Experiences (R25)
  (PAR-17-221)
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): May 24, 2017; May 24, 2018; May 24, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Revision Applications to NCI-supported R01 Awards to Include Research on the NCI's Provocative Questions (R01)
  (RFA-CA-17-019)
  National Cancer Institute
  Application Receipt Date(s): June 28, 2017; October 30, 2017; June 28, 2018; October 30, 2018, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Revision Applications to National Cancer Institute (NCI)-supported U01 Awards to Include Research on the NCI's Provocative Questions (U01)
  (RFA-CA-17-020)
  National Cancer Institute
  Application Receipt Date(s): June 28, 2017; October 30, 2017; June 28, 2018; October 30, 2018, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Revision Applications to National Cancer Institute (NCI)-supported P01 Awards to Include Research on the NCI's Provocative Questions (P01)
  (RFA-CA-17-021)
  National Cancer Institute
  Application Receipt Date(s): June 28, 2017; October 30, 2017; June 28, 2018; October 30, 2018, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Revision Applications to National Cancer Institute (NCI)-supported P50 Awards to Include Research on the NCI's Provocative Questions (P50)
  (RFA-CA-17-022)
  National Cancer Institute
  Application Receipt Date(s): June 28, 2017; October 30, 2017; June 28, 2018; October 30, 2018, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates.
• Pragmatic Research in Healthcare Settings to improve Kidney Disease Prevention and Care (R18)
  (RFA-DK-17-008)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): October 24, 2017), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Advancing Conformance with the Voluntary National Retail Food Regulatory Program Standards (VNRFRPS) (U18)
  (RFA-FD-17-007)
  Food and Drug Administration
  Application Receipt Date(s): May 31, 2017, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Sleep Health and Circadian Biology in HIV-Related Comorbidities (R01)
  (RFA-HL-18-005)
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): August 9, 2017, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on this date.
• Limited Competition: Genomics and Informatics Center for the SubPopulations and InteRmediate Outcomes Measures In COPD Study (SPIROMICS) (U24)
  (RFA-HL-18-011)
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): June 20, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Center for Coordination of Analytics, Science, Enhancement , and Logistics (CASEL) in Tobacco Regulatory Science (U54)
  (RFA-OD-17-002)
  National Institutes of Health
  National Institute on Drug Abuse
  Food and Drug Administration
  Office of Disease Prevention
  U.S. Food and Drug Administration, Center for Tobacco Products
  Application Receipt Date(s): July 19, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Tobacco Centers of Regulatory Science for Research Relevant to the Family Smoking Prevention and Tobacco Control Act (U54)
  (RFA-OD-17-003)
  National Institutes of Health
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute of Environmental Health Sciences
  National Heart, Lung, and Blood Institute
  Food and Drug Administration
  Office of Disease Prevention
  U.S. Food and Drug Administration, Center for Tobacco Products
  Application Receipt Date(s): July, 19, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.